KALOBIOS PHARMACEUTICALS INC's ticker is KBIO and the CUSIP is 48344T100. A total of 46 filers reported holding KALOBIOS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $7,000 | +40.0% | 14,976 | +37.4% | 0.00% | – |
Q1 2015 | $5,000 | -96.8% | 10,900 | -87.9% | 0.00% | – |
Q4 2014 | $155,000 | +158.3% | 90,232 | +127.9% | 0.00% | – |
Q3 2014 | $60,000 | -81.1% | 39,596 | -71.8% | 0.00% | – |
Q2 2014 | $318,000 | -12.9% | 140,281 | +3.9% | 0.00% | – |
Q1 2014 | $365,000 | -52.0% | 135,006 | -21.7% | 0.00% | -100.0% |
Q4 2013 | $760,000 | -9.6% | 172,379 | -7.6% | 0.00% | 0.0% |
Q3 2013 | $841,000 | – | 186,493 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,632,928 | $11,901,000 | 3.36% |
DAFNA Capital Management LLC | 250,000 | $1,130,000 | 1.23% |
WALL STREET ASSOCIATES | 625,200 | $2,826,000 | 0.26% |
Lehman Brothers Holdings Inc. | 942,092 | $4,258,000 | 0.20% |
Old West Investment Management, LLC | 54,517 | $246,000 | 0.12% |
WEXFORD CAPITAL LP | 278,460 | $1,259,000 | 0.10% |
CLOUGH CAPITAL PARTNERS L P | 400,000 | $1,808,000 | 0.06% |
SABBY MANAGEMENT, LLC | 105,408 | $476,000 | 0.03% |
PRIMECAP MANAGEMENT CO/CA/ | 4,706,675 | $21,274,000 | 0.03% |
TUDOR INVESTMENT CORP ET AL | 125,000 | $565,000 | 0.02% |